SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-020633
Filing Date
2024-02-27
Accepted
2024-02-27 08:00:41
Documents
104
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K verv-20231231.htm   iXBRL 10-K 3604188
2 EX-10.7 verv-ex10_7.htm EX-10.7 120379
3 EX-10.8 verv-ex10_8.htm EX-10.8 62772
4 EX-10.9 verv-ex10_9.htm EX-10.9 59464
5 EX-10.10 verv-ex10_10.htm EX-10.10 33329
6 EX-10.17 verv-ex10_17.htm EX-10.17 308173
7 EX-10.24 verv-ex10_24.htm EX-10.24 125779
8 EX-10.29 verv-ex10_29.htm EX-10.29 237669
9 EX-23.1 verv-ex23_1.htm EX-23.1 7455
10 EX-31.1 verv-ex31_1.htm EX-31.1 15718
11 EX-31.2 verv-ex31_2.htm EX-31.2 15710
12 EX-32.1 verv-ex32_1.htm EX-32.1 8962
13 EX-32.2 verv-ex32_2.htm EX-32.2 9127
14 EX-97 verv-ex97.htm EX-97 34168
15 GRAPHIC img244475160_0.jpg GRAPHIC 240368
16 GRAPHIC img244475160_1.jpg GRAPHIC 1019
17 GRAPHIC img244475160_2.jpg GRAPHIC 19659
18 GRAPHIC img244475160_3.jpg GRAPHIC 1019
19 GRAPHIC img244475160_4.jpg GRAPHIC 57192
20 GRAPHIC img244475160_5.jpg GRAPHIC 230567
  Complete submission text file 0000950170-24-020633.txt   14943384

Data Files

Seq Description Document Type Size
21 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT verv-20231231.xsd EX-101.SCH 1766257
106 EXTRACTED XBRL INSTANCE DOCUMENT verv-20231231_htm.xml XML 1988745
Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40489 | Film No.: 24682043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)